Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dahele

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?C Dickhoff, K J Hartemink, J Kooij, et al.
Current Oncology (Toronto, Ont.)|December 15, 2007
Integrating regional and community lung cancer services to improve patient careM Dahele, Y Ung, J Meharchand, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2023
Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancerC Dickhoff, S Unal, D J Heineman, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2014
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLCI Bahce, C G Vos, C Dickhoff, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancerC Dickhoff, M Dahele, M A Paul, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2014
Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and functionC Dickhoff, K J Hartemink, P M van de Ven, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 24, 2013
Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumorsC G Vos, M Dahele, J R van Sörnsen de Koste, et al.
JTO Clinical and Research Reports|March 27, 2023
Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus TumorsS Ünal, J A Winkelman, D J Heineman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 4, 2011
Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: pilot experience with 18F-fluorodeoxyglucose positron emission tomography-computed tomographyM Dahele, M Freeman, S Pearson, et al.
Current Oncology (Toronto, Ont.)|November 15, 2008
Developing a methodology for three-dimensional correlation of PET-CT images and whole-mount histopathology in non-small-cell lung cancerM Dahele, D Hwang, C Peressotti, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?C Dickhoff, K J Hartemink, J Kooij, et al.
Current Oncology (Toronto, Ont.)|December 15, 2007
Integrating regional and community lung cancer services to improve patient careM Dahele, Y Ung, J Meharchand, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2023
Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancerC Dickhoff, S Unal, D J Heineman, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2014
Metabolic activity measured by FDG PET predicts pathological response in locally advanced superior sulcus NSCLCI Bahce, C G Vos, C Dickhoff, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancerC Dickhoff, M Dahele, M A Paul, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2014
Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and functionC Dickhoff, K J Hartemink, P M van de Ven, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 24, 2013
Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumorsC G Vos, M Dahele, J R van Sörnsen de Koste, et al.
JTO Clinical and Research Reports|March 27, 2023
Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus TumorsS Ünal, J A Winkelman, D J Heineman, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 4, 2011
Early metabolic response evaluation after stereotactic radiotherapy for lung cancer: pilot experience with 18F-fluorodeoxyglucose positron emission tomography-computed tomographyM Dahele, M Freeman, S Pearson, et al.
Current Oncology (Toronto, Ont.)|November 15, 2008
Developing a methodology for three-dimensional correlation of PET-CT images and whole-mount histopathology in non-small-cell lung cancerM Dahele, D Hwang, C Peressotti, et al.
Pageof 3